Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zhuoqing Qiao"'
Autor:
Jing-wen Niu, Yuhang Li, Chen Xu, Hongxia Sheng, Chong Tian, Hongmei Ning, Jiangwei Hu, Jianlin Chen, Botao Li, Jun Wang, Xiao Lou, Na Liu, Yongfeng Su, Yao Sun, Zhuoqing Qiao, Lei Wang, Yu Zhang, Sanchun Lan, Jing Xie, Jing Ren, Bo Peng, Shenyu Wang, Yanping Shi, Long Zhao, Yijian Zhang, Hu Chen, Bin Zhang, Liangding Hu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMesenchymal stromal cells (MSCs) have been extensively studied as a potential treatment for steroid refractory acute graft-versus-host disease (aGVHD). However, the majority of clinical trials have focused on bone marrow-derived MSCs.Meth
Externí odkaz:
https://doaj.org/article/fa8fd6d4dac74b06959ff11884897ad9
Autor:
Yuxin Wang, Yao Sun, Jing Xie, Jiangwei Hu, Na Liu, Jianlin Chen, Botao Li, Sanchun Lan, Jingwen Niu, Lei Wang, Zhuoqing Qiao, Yu Zhang, Jing Ren, Bin Zhang, Liren Qian, Yehui Tan, Liping Dou, Yuhang Li, Liangding Hu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Myelodysplastic syndrome (MDS) with TP53 mutations has a poor prognosis after transplantation, and novel therapeutic means are urgently needed. Decitabine (Dec) monotherapy has demonstrated improved overall response rates in MDS and acute myeloid leu
Externí odkaz:
https://doaj.org/article/850aabf99da44c5baa251950bf8d4756
Autor:
Yao Sun, Yongfeng Su, Yizhi Wang, Na Liu, Yuhang Li, Jianlin Chen, Zhuoqing Qiao, Jingwen Niu, Jiangwei Hu, Bin Zhang, Hongmei Ning, Liangding Hu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectivesAt present, reinfusions of chimeric antigen receptor (CAR)-T cell have exhibited limited efficacy, while their efficacy on extramedullary relapse remains to be further elucidated in B-cell acute lymphoblastic leukemia (B-ALL). Although comb
Externí odkaz:
https://doaj.org/article/16099ba164634717ac6a526d5b199830
Autor:
Jingwen Niu, Yuhang Li, Chen Xu, Hongxia Sheng, Chong Tian, Hongmei Ning, Jiangwei Hu, Jianlin Chen, Botao Li, Jun Wang, Xiao Lou, Na Liu, Yongfeng Su, Yao Sun, Zhuoqing Qiao, Lei wang, Yu zhang, Sanchun Lan, Jing Xie, Jing Ren, Hu Chen, Bin Zhang, Liangding Hu
Background: Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation. First-line treatment of aGVHD is corticosteroid. Second-line therapy mainly comprises immunosuppressants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78a006ce48087d10b0cde03aaf49308d
https://doi.org/10.21203/rs.3.rs-2000014/v1
https://doi.org/10.21203/rs.3.rs-2000014/v1
Publikováno v:
Autoimmunity. 49:50-57
This study compared the effects of different dosages of intravenous immunoglobulin (IVIg) against immune thrombocytopenia (ITP). A total of 167 patients, 91 adults and 76 children, with ITP, followed-up for three years in the case-control study, were
Autor:
Yao, Sun, Jianlin, Chen, Zhuoqing, Qiao, Yuhang, Li, Jiangwei, Hu, Guoliang, Hu, Hongmei, Ning, Bin, Zhang, Liangding, Hu
Publikováno v:
Frontiers in Immunology; 4/1/2021, Vol. 11, pN.PAG-N.PAG, 9p
Autor:
Qingguo Liu, Li-hua Wu, Ning Xu, Lianlian Li, Zhuoqing Qiao, Jing-Yi Yu, Shangzhu Li, Yimin Hu, Lingjie Sun, Pingping Huang
Publikováno v:
Cytotherapy. 16:1110-1116
Background aims Autologous transplantation of granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells (M-PBMNCs) has been shown to be effective in treating critical limb ischemia (CLI); however, the studies of the possibl
Publikováno v:
Blood. 126:3480-3480
This study compared the effects of different dosages of intravenous immunoglobulin (IVIg) against immune thrombocytopenia. A total of 167 patients, 91 adults and 76 children, with ITP, followed-up for 3 years in the case-control study, were each divi
Autor:
LINGJIE SUN1, LIHUA WU1, ZHUOQING QIAO2, JINGYI YU1, LIANLIAN LI1, SHANGZHU LI1, QINGGUO LIU1, YIMIN HU1, NING XU1, PINGPING HUANG1 huangpp@ihcams.ac.cn
Publikováno v:
Cytotherapy (Elsevier Inc.). Aug2014, Vol. 16 Issue 8, p1110-1116. 7p.